Robert F. Furchgott Society at SUNY Downstate Health Sciences University Announces New Leadership:
Jul 16, 2010
Dr. Henri Tiedge and Dr. Daniel Rosenbaum Named to Top Positions
Two leading faculty researchers at SUNY Downstate Health Sciences University have been appointed to head the Robert F. Furchgott Society. Henri Tiedge, PhD, professor of physiology and pharmacology and of neurology, and Daniel Rosenbaum, MD, professor and chair of neurology, have been named president and vice-president, respectively.
Drs. Tiedge and Rosenbaum are two of the most widely respected researchers in their fields. They take the helm of a membership organization dedicated to promoting research excellence and advancing the careers of young scientists.
Dr. Tiedge is a National Institutes of Health (NIH)-funded investigator known for his research on the mechanisms of neuronal gene expression, RNA transport, and RNA control of neuronal function. He is a reviewer for several scientific journals and has served on review committees of various funding organizations, including the NIH and Department of Defense.
Dr. Rosenbaum is cited by his peers as one of the “Best Doctors in New York” and “Best Doctors in America.” His clinical and basic research focuses on neurological disorders and stroke and he has been continuously funded by the NIH for more than 20 years. Dr. Rosenbaum has served on NIH review committees and has published more than 90 articles in all of the top-tier journals.
The Robert F. Furchgott Society provides support to postdoctoral basic researchers, clinical fellows, residents, graduate students, and medical undergraduates; underwrites the cost of presentations at professional conferences; and sponsors an annual visiting professorship and lecture series.
The Society was established in 2005 as a tribute to the achievements of the late Dr. Furchgott, former chairman and professor emeritus of pharmacology and winner of the 1998 Nobel Prize in physiology or medicine. Dr. Furchgott's discoveries have helped scientists understand and find new treatments for cardiovascular diseases and a host of other conditions, ranging from immune disorders to memory loss, pulmonary disease, and erectile dysfunction. The entire course of his prize-winning research was performed in his laboratory at SUNY Downstate.
###
About SUNY Downstate Health Sciences University
Downstate Health Sciences University in Brooklyn is one of four academic health centers (AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY AMC in New York City dedicated to health education, research, and patient care for the borough’s 2.7 million residents. Its flagship hospital, University Hospital at Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s exceptional medical school and world-class academic center research facilities. With a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate offers comprehensive healthcare services to the community.
UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond its clinical expertise, Downstate houses a range of esteemed educational institutions, including its College of Medicine, College of Nursing, School of Health Professions, School of Graduate Studies, and School of Public Health. Downstate fosters innovation through its multifaceted biotechnology initiative, the Biotechnology Incubator and BioBAT, which support early-stage and more mature biotech companies.